| Name | Title | Contact Details |
|---|
2023 Earthshot Prize Finalist on a mission to protect the planet from the cost of clothing. At Circ, weve created a technology system that returns clothes to the raw materials from which they were made. Again and again. Brand partners like Patagonia, Marubeni, and Fashion For Good are joining us in our goal of turning wasteful fashion lines into renewable fashion circles. By 2030, we expect to have recycled 10 billion garments, represent 10% of the global apparel market, and to have saved more than 100 million trees. As our ecology and economy grow evermore entwined, it is clear to us that the world already has all the clothing it needs to create all the clothing it will ever need. Join us in threading together the future of circular fashion and eliminating our collective fashion footprint.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Livspace is one of the largest and fastest-growing home interiors and renovation companies. Using its proprietary technology, Livspace provides a one-stop renovation solution for homeowners—from design to managed last mile fulfillment for all rooms in a home. The Brand Has organized a fragmented industry, bringing together designers, brands, manufacturers and contractors to enable an eCommerce-like trusted and predictable experience. Livspace currently serves the Middle East, and Singapore, as well as 50+ metro and non-metro areas in India. Livspace has showcased phenomenal growth since its launch, having delivered over 120,000 rooms and selling over 5 million SKUs through its platform. The company has raised around USD 450 million in capital from some of the top global investors including KKR, Ingka Group Investments (part of largest IKEA retailer Ingka Group), TPG Growth, Goldman Sachs, Kharis Capital, Venturi Partners, FFP (Peugeot Groups Holding Company), EDBI, Bessemer Venture Partners, Jungle Ventures, Helion Ventures and UC-RNT.
Providing real-time asset tracking in any environment, with applications in manufacturing, defense, energy, inventory management, logistics, and security. WISERs ultra-wideband (UWB) system operates without line-of-sight and registers asset locations within inches in most cases.